HBOT & Parkinson’s: Oxygenating Hope

Parkinson’s disease has long been a challenging neurological condition, affecting millions worldwide. Its hallmark symptoms—tremors, rigidity, and bradykinesia—are well-known, but the impacts run much deeper, affecting cognition, mood, digestion, and sleep. At Chicago Neuro, we explore innovative approaches like Hyperbaric Oxygen Therapy (HBOT), which a growing body of research and clinical observation suggests may offer additional support in ways that conventional managements cannot.
As more patients and doctors explore HBOT for neurological wellness, questions arise about how this oxygen-based therapy works for those living with Parkinson’s, what the current research shows, and who might benefit most.
Understanding Parkinson’s Disease Beyond Motor Symptoms
Parkinson’s is widely misunderstood as simply a disorder of movement. While tremors and slow movements are central, many people with Parkinson’s also experience:
- Cognitive decline and memory challenges
- Depression and anxiety
- Sleep disturbances, including REM sleep behavior disorder
- Digestive issues, such as constipation
- Fatigue and low energy
These diverse symptoms reflect widespread neural disruption involving dopamine-producing neurons and other neurotransmitter systems. Central to this disruption is chronic neuroinflammation, oxidative stress, and mitochondrial dysfunction—areas that HBOT may directly influence.
What is HBOT and How Does It Work?
Hyperbaric Oxygen Therapy involves breathing pure oxygen inside a pressurized chamber, increasing oxygen availability in the bloodstream and tissues. At higher atmospheric pressures, oxygen dissolves more efficiently into blood plasma, traveling deeper into tissues, including the brain.
Unlike simple oxygen supplementation, HBOT supercharges oxygen delivery, allowing it to reach regions compromised by poor blood flow or damaged cells.
Core Benefits of HBOT for the Brain:
- Increased oxygenation to neurons
- Improved mitochondrial energy production (ATP)
- Reduced oxidative stress
- Modulation of inflammation
- Stimulation of neuroplasticity (brain’s ability to adapt and form new connections)
The Role of Inflammation and Oxidative Stress in Parkinson’s
Research highlights inflammation and oxidative stress as major drivers of neuronal degeneration in Parkinson’s. When brain cells are exposed to excessive inflammation, they are damaged over time, leading to reduced dopamine levels and the progressive loss of motor and cognitive abilities.
HBOT has shown in numerous studies to downregulate inflammatory markers, while simultaneously increasing antioxidant capacity in brain tissue. This dual action offers promising support for brain health.
Key Inflammatory Factors in Parkinson’s:
- Elevated cytokines (IL-1, IL-6, TNF-alpha)
- Chronic microglial activation (brain’s immune cells stuck in overdrive)
- Reduced antioxidant defenses (e.g., glutathione levels)
How HBOT May Influence These Factors:
- Boosts antioxidant enzyme activity
- Reduces harmful inflammation
- Enhances blood flow, promoting nutrient and oxygen delivery to the brain
HBOT and Mitochondrial Function: Powering Up Brain Cells
Another crucial aspect of Parkinson’s is mitochondrial dysfunction. Mitochondria are the energy factories of cells, and in Parkinson’s, their ability to generate ATP is often impaired. This lack of energy impacts not only movement but cognition and mood.
HBOT has been shown to enhance mitochondrial efficiency, improve oxygen usage in cells, and restore energy balance, potentially offering meaningful support for those whose neurons are struggling to function properly.
Clinical Observations: What Are Doctors and Patients Reporting?
Though large-scale studies are still ongoing, there are encouraging reports from both physicians and individuals using HBOT as part of a comprehensive approach to Parkinson’s care.
Commonly Reported Benefits Include:
- Improved motor coordination
- Decrease in muscle rigidity
- Sharper cognitive function
- Reduced episodes of freezing
- Enhanced mood and reduced anxiety
Many individuals report better energy and less fatigue—an often-overlooked but deeply impactful symptom of Parkinson’s.
Patient Report Example:
“After my fourth HBOT session, I noticed I was moving with less effort. My thoughts were clearer, and I even had more energy to enjoy a walk with my family. It’s given me hope again.” — Individual using HBOT alongside conventional care
Research on HBOT and Neurodegenerative Diseases: What Do Studies Say?
While more Parkinson’s-specific studies are needed, research on HBOT in related neurodegenerative conditions, including traumatic brain injury, stroke, and dementia, suggests a broad neuroprotective effect:
- Reduced neural inflammation
- Improved cognitive function
- Enhanced repair of brain tissue
- Improved circulation in brain regions involved in movement and cognition
A 2022 study in Medical Gas Research noted that HBOT promoted brain cell repair and improved neurological outcomes in experimental models that share pathological features with Parkinson’s, including oxidative damage and mitochondrial dysfunction.
HBOT as Part of a Comprehensive Parkinson’s Strategy
It’s essential to understand that HBOT is not a standalone approach but may serve as a powerful complement to existing strategies. This includes:
- Medication regimens (e.g., dopamine replacement therapy)
- Physical therapy to improve strength and coordination
- Speech and occupational therapy for functional support
- Nutritional adjustments for brain and gut health
HBOT may amplify the benefits of these modalities by supporting brain oxygenation, reducing inflammation, and boosting mitochondrial function.
Who Should Consider HBOT for Parkinson’s?
Ideal Candidates:
- Individuals early in Parkinson’s progression aiming to slow neurological decline
- Those struggling with fatigue, brain fog, or muscle rigidity
- Individuals seeking to optimize brain resilience and function alongside conventional care
Important Considerations:
Before beginning HBOT, patients should work with neurologists and HBOT professionals to assess candidacy. Factors like cardiovascular health, lung conditions, and seizure history must be evaluated to ensure safety.
What to Expect During HBOT Sessions
A typical session involves sitting or reclining comfortably in a hyperbaric chamber while breathing pure oxygen. Sessions typically last 60 to 90 minutes, and most protocols involve a series of sessions (often 20-40) to achieve optimal benefits.
Patients often report feeling relaxed during and after sessions, though mild ear pressure changes (like flying on an airplane) are common.
The Future of HBOT for Parkinson’s Disease: Where Research Is Headed
As interest grows, new clinical trials are examining how HBOT can impact neurodegenerative processes in Parkinson’s. Focus areas include:
- Brain imaging to assess structural and functional changes post-HBOT
- Biomarkers of inflammation and oxidative stress
- Cognitive and motor function assessments
Research is also exploring how HBOT may influence neurogenesis (growth of new brain cells), a hopeful frontier for restoring function in Parkinson’s patients.
Moving Toward a More Comprehensive Approach to Parkinson’s Care
Parkinson’s is a complex condition requiring a multifaceted approach. By incorporating HBOT into a broader care plan, patients may gain additional tools to support brain health, mobility, and daily quality of life.
As research continues to uncover the profound ways oxygen influences brain function, HBOT stands as a beacon of possibility for those living with Parkinson’s. It offers more than just hope—it opens the door to practical, science-backed support for living better with this challenging condition.
Hyperbaric oxygen therapy (HBOT) has been making headlines recently, highlighting its wide range of applications and the vital need for strict safety measures. A notable example is Pope Francis, whose health improvement has been linked to high-flow oxygen therapy, demonstrating its potential benefits.
For more information about HBOT, call (312) 767.3500 or find an Oxygen therapy clinic near you.
Resources:
- Ortega MA, Fraile-Martinez O, García-Montero C, Callejón-Peláez E, Sáez MA, Álvarez-Mon MA, García-Honduvilla N, Monserrat J, Álvarez-Mon M, Bujan J, Canals ML. A General Overview on the Hyperbaric Oxygen Therapy: Applications, Mechanisms and Translational Opportunities. Medicina (Kaunas). 2021 Aug 24;57(9):864. doi: 10.3390/medicina57090864. PMID: 34577787; PMCID: PMC8465921.
- Marcinkowska AB, Mankowska ND, Kot J, Winklewski PJ. Impact of Hyperbaric Oxygen Therapy on Cognitive Functions: a Systematic Review. Neuropsychol Rev. 2022 Mar;32(1):99-126. doi: 10.1007/s11065-021-09500-9. Epub 2021 Apr 13. PMID: 33847854; PMCID: PMC8888529.
- Barata P, Camacho O, Lima CG, Pereira AC. The Role of Hyperbaric Oxygen Therapy in Neuroregeneration and Neuroprotection: A Review. Cureus. 2024 Jun 10;16(6):e62067. doi: 10.7759/cureus.62067. PMID: 38989389; PMCID: PMC11235151.
- Yiğit U, Erdenöz S, Uslu U, Oba E, Cumbul A, Cağatay H, Aktaş S, Eskicoğlu E. An immunohistochemical analysis of the neuroprotective effects of memantine, hyperbaric oxygen therapy, and brimonidine after acute ischemia reperfusion injury. Mol Vis. 2011 Apr 26;17:1024-33. PMID: 21541269; PMCID: PMC3084223.